Skip to main content
Caplight Logo









Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://www.wp-hz.com/

Last Round

Series B

Feb 20, 2024

Company Overview

Westlake Pharmaceuticals (Hangzhou) Co., Ltd. is a biotechnology company that develops first-in-class small molecule drugs for oncology and infectious diseases using an AI-driven drug discovery platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

small molecule drugsdrug discoveryAI drug discoverybiotechoncologyinfectious diseasecomputational drug designfirst-in-class drugsmedicinal chemistrypharmacokinetic evaluationdrug pipelinein silico drug discoveryAI-first biotechpharma R&Ddrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Westlake Pharmaceuticals (Hangzhou) Co., Ltd. Comparables

Compare Westlake Pharmaceuticals (Hangzhou) Co., Ltd. with similar companies based on industry and business-model similarity.

Westlake Pharmaceuticals (Hangzhou) Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MindRank
85%
Genesis Therapeutics
84%
Accutar Biotechnology
82%

Westlake Pharmaceuticals (Hangzhou) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 20, 2024
Series ANov 1, 2022
AngelDec 1, 2020

Westlake Pharmaceuticals (Hangzhou) Co., Ltd. Investors

Notable investors and investment history

Westlake Pharmaceuticals (Hangzhou) Co., Ltd. investors
InvestorRounds
CAS StarAngel
Zhejiang Financial HoldingSeries B
HongShan Capital Group (HSG)Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 20, 2024

    Raised Series B round with Zhejiang Financial Holding.

  • Nov 1, 2022

    Completed a Series A funding round.

Westlake Pharmaceuticals (Hangzhou) Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Westlake Pharmaceuticals (Hangzhou) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Westlake Pharmaceuticals (Hangzhou) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Year Founded2020
Last FundingFeb 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?